1. Pathology of pulmonary hypertension;Tuder;Clin Chest Med,2007
2. Department of Health and Ageing Drug Utilisation Subcommittee, Commonwealth Department of Health and Ageing statistics 2003-8, Canberra, Australia 2010 http://www.health.gov.au/internet/main/publishing.nsf/Content/Publications+Statistics+&+Resources-1
3. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study;Channick;Lancet,2001
4. Bosentan therapy for pulmonary arterial hypertension;Rubin;N Engl J Med,2002
5. Actelion Bosentan Patient Registry flyer presented at Industry Stand, Thoracic Society Australia and New Zealand Annual Scientific Meeting, Melbourne 2010